![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Helix BioPharma is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's clinical product development initiatives include Topical Interferon Alph... Helix BioPharma is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's clinical product development initiatives include Topical Interferon Alpha-2b, for the treatment of conditions caused by the human papilloma virus. Helix is also developing its novel L-DOS47 new drug product candidate for the treatment of lung adenocarcinoma. Show more
Tue, Apr 02, 2013 12:00 - Helix Biopharma Corp. (HBPC: Grey Market) - Symbol Change - The symbol, HBPC, is no longer a valid symbol for Helix Biopharma Corp.. As of Tue, Apr 02, 2013, the new...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0.1662 | 0.1662 | 0.1662 | 1000 | 0.1662 | CS |
12 | 0 | 0 | 0.1662 | 0.1662 | 0.1662 | 1000 | 0.1662 | CS |
26 | 0.0249 | 17.6220806794 | 0.1413 | 0.1662 | 0.1377 | 970 | 0.15037533 | CS |
52 | 0.0249 | 17.6220806794 | 0.1413 | 0.1662 | 0.1377 | 970 | 0.15037533 | CS |
156 | -0.5388 | -76.4255319149 | 0.705 | 0.723474 | 0.1377 | 981 | 0.3114119 | CS |
260 | -0.3501 | -67.8094131319 | 0.5163 | 1.1481 | 0.1377 | 1592 | 0.54081767 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions